University of Pennsylvania
Carl June is a pioneer of CAR-T cell therapy who developed the first FDA-approved gene therapy, Kymriah, for cancer treatment. His work in engineering patients' own immune cells to attack tumors has transformed cancer immunotherapy.
179
H-INDEX
1420
PUBLICATIONS
40
GRANTS
38
PATENTS
INDUSTRY TIES
Novartis
Tmunity Therapeutics
Capstan Therapeutics
TRY IT
Install the CLI and run your first search in under a minute. No account required to explore.
npx sci-buy@latest COPIED